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A B S T R A C T
In this study, we investigated the therapeutic potential of bone marrow mononuclear cells (BMCs) in a
model of epilepsy induced by pilocarpine in rats. BMCs obtained from green ﬂuorescent protein (GFP)
transgenic mice or rats were transplanted intravenously after induction of status epilepticus (SE).
Spontaneous recurrent seizures (SRS)weremonitoredusingRacine’s seizure severity scale. All of the rats in
the saline-treated epileptic control group developed SRS, whereas none of the BMC-treated epileptic
animals had seizures in the short term (15 days after transplantation), regardless of the BMC source. Over
the long-term chronic phase (120 days after transplantation), only 25% of BMC-treated epileptic animals
had seizures, butwith a lower frequencyandduration compared to the epileptic control group. Thedensity
of hippocampal neurons in the brains of animals treated with BMCs was markedly preserved. At
hippocampal Schaeffer collateral-CA1 synapses, long-term potentiation was preserved in BMC-
transplanted rats compared to epileptic controls. The donor-derived GFP+ cells were rarely found in the
brains of transplanted epileptic rats. In conclusion, treatment with BMCs can prevent the development of
chronic seizures, reduce neuronal loss, and inﬂuence the reorganization of the hippocampal neuronal
network.
 2010 Published by Elsevier Ltd on behalf of British Epilepsy Association.
Contents lists available at ScienceDirect
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Temporal lobe epilepsy (TLE) is the most prevalent form of
refractory symptomatic epilepsy.1 TLE is generally associated with
an initial brain insult followed by a variable latent period, which is
when epileptogenic processes take place. Subsequently, this
process eventually leads to spontaneous recurrent seizures
(SRS), i.e., the chronic phase.2
At the structural level, temporal lobe epilepsy in humans and in
animalmodels is associatedwith a loss of neurons in CA1-CA3 areas
of the hippocampus, astrogliosis and formation of recurrent
connections between mossy ﬁbers.3,4 Surgical treatment is usually
indicated for patients with medically refractory mesial temporal
lobe epilepsy, but is limited to those with unilateral hippocampal* Corresponding author at: Instituto do Ce´rebro, Pontifı´cia Universidade Cato´lica
do Rio Grande do Sul (PUCRS), Av. Ipiranga 6690, 90610-000, Porto Alegre, RS, Brazil.
Tel.: +55 51 33203250; fax: +55 51 33203312.
E-mail address: jcc@pucrs.br (J.C. daCosta).
1059-1311/$ – see front matter  2010 Published by Elsevier Ltd on behalf of British
doi:10.1016/j.seizure.2009.12.003sclerosis and adequate functional reserves contralateral to the
proposed surgical site (see Paglioli).5,6 Given the high incidence and
the limited treatments available for this disease, the development of
new therapeutic strategies to decrease or prevent the neuronal
alterations associated with epilepsy is of great interest.
Transplantation of stem cells is a potential strategy for the
treatment of neurological diseases such as epilepsy. Transplanted
cells may have therapeutic effects either by preventing or by
suppressing SRS.7,8 Several reports have also indicated that adult
stem cells are pluripotent and generate cell types characteristic of
host organs after in vivo transplantation. A number of studies have
demonstrated that bone marrow stem cells can differentiate into
other cell types, including osteoblasts, adipocytes, chondrocytes,
tenocytes, skeletal myocytes,9 cardiomyocytes,10 hepatocytes11
and neural cells.12–15
Some studies have examined the therapeutic potential of bone
marrow mononuclear cells (BMC) and mesenchymal stromal cells
(MSC) in CNS disorders using different experimental models.
Recently, in a rodent brain ischemia model, rat BMCs16–21 and/or
MSCs22–24 were shown to be highly efﬁcient in inducing functionalEpilepsy Association.
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tion were also observed in rat models of spinal cord injury and
brain trauma.25,26
Moreover, neuroprotection could only be observed at low levels
and these therapeutic effects seemed to be explained by paracrine
actions of the transplanted cells. This therapeutic mechanism has
been suggested by studies showing that BMCs stimulate endoge-
nous glial cells or neural stem cells, reduce neuronal apoptosis and
neurodegeneration, modulate inﬂammatory responses and pro-
mote self-repair mechanisms in the brain.16,19,21,27,28 In addition,
these cells are able to release many trophic factors and cytokines
involved in tissue repair and regeneration.22,25,29–31
In this report, we investigated the effects of transplantated
BMCs on the epileptogenic process. We examined these effects
during early epileptogenesis and during the chronic phase in a
model of epilepsy induced by pilocarpine in rats.32,33
2. Methods
2.1. Animals
Male Wistar rats (40–45 days of age, 110–130 g) were used to
induce epilepsy and also as normal controls. Food and drinking
waterwere available ad libitum. EGFP transgenic adultmale C57BL/
6 mice and male Wistar rats were used as BMC donors. EGFP
transgenic mice were bred at the Animal Facility of Gonc¸alo Moniz
Research Center, FIOCRUZ, BA, Brazil. All animal procedures were
approved by the Animal Care and Ethics Committee of Pontifı´cia
Universidade Cato´lica do Rio Grande do Sul, RS, Brazil. All
experiments were conducted in a blinded manner relative to theFig. 1. Electrophysiological properties of brain sections of normal and epileptic rats. H
epileptic controls at 10 and 120 days after SE. (A) Insets are superimposed representati
48 min; dark line) tetanic stimulation in non-epileptic control (a and d), in saline-epilept
non-epileptic control (dark squares), saline-epileptic (open triangles), and BMC-epileptic
Data are presented as mean S.E.M.treatment condition of the animals. Every effort was made to
minimize the animal’s suffering and to reduce the number of
animals used. The ‘‘Principles of laboratory animal care’’ (NIH
publication no. 85-23, revised 1996) were strictly followed.
2.2. Induction of SE and epilepsy
For the induction of SE and the subsequent epileptic state, all rats
had seizures received lithium chloride (127 mg/kg, i.p.; Sigma–
Aldrich, St. Louis, MO). On the following day, methylscopolamine
bromide (1 mg/kg, i.p. in 0.9% NaCl) was administered to limit the
peripheral effects of the convulsant. SE was induced by injecting
pilocarpine (40 mg/kg, i.p.; adapted from Clifford)33 30 min later.
The severity of convulsions was rated according to Racine’s scale,34
and only those animals that displayed class V behavioral seizures
wereused in the study. Seizure activitywas terminatedbydiazepam
injection (10 mg/kg, i.p.) at 90 min post-onset of SE. The lithium (Li)
and pilocarpine (pilo) treated rats with SE are referred to as the
epilepsy group, n = 135. The normal control group was treated only
with saline solution and are referred to as non-epileptic controls,
n = 28.
2.3. Preparation of bone marrow cells
Bone marrow cells were harvested from EGFP transgenic mice
or male Wistar rats. The animals were killed with 200 ml of 8%
ketamine hydrochloride (Crista´lia, Brazil) and 2% chlorpromazine
(Unia˜o Quı´mica, Brazil), which was followed by dissection. Fresh
bone marrow was extracted from the humerus, femurs and tibiae
by ﬂushing with PBS. After centrifugation, the cell pellet wasippocampal slices were prepared from, saline-epileptic, BMC-epileptic and non-
ve traces of the averaged fEPSPs before (20 to 15 min; gray line) and after (44–
ic (b and e), and BMC-epileptic (c and f) groups. Normalized amplitudes of fEPSPs in
(open circles) groups killed 10 (B) and 120 (C) days after SE (n = 9–10 slices/group).
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gradient generated by centrifugation over a Ficoll-Hypaque
solution (Histopaque 1119 and 1077, 1:1; Sigma, St. Louis, MO)
at 400  g for 30 min at room temperature. The mononuclear
fraction over the Ficoll-Paque layer was collected and washed
twice with PBS. BMCs obtained from rats were incubated with
Qtracker (Invitrogen – Molecular Probes, Carlsbad, CA, USA)
according to the manufacturer’s instructions.
2.4. Flow cytometric analysis
For detection of surface antigen,mononuclear cellswerewashed
with saline and incubated at 4 8C for 30 min with conjugated
antibodies against murine CD34 PE, CD90 PE, CD11b PE, CD44 PE,
CD117Cy5,CD45APCandSca-1Cy5(BDPharmingen,SanDiego,CA).
Excess antibody was removed by washing. Labeled cells were
collected and analyzed using a FACScalibur cytometer (Becton
Dickinson, San Diego, CA) with CellQuest software. At least 50,000
datapointswerecollected.Themean S.D. for themarkersexpressed
by mononuclear cells were CD34 (4.860 0.43), CD45 (96.36  1.80),
CD117 (13.95  0.88), CD11b (60.22  3.30), CD44 (95.61 1.78),
CD90 (8.100  1.28), Sca1 (36.06 1.8) and GFP (96.52 0.76).
2.5. Transplantation of BMCs
After injection of diazepam, epileptic animals were randomly
assigned to the following groups: BMC-epileptic group receiving
transplantation of mouse BMC (n = 80) or rat BMC (n = 5), saline-
epileptic group (was injected with saline solution n = 50) and non-
epileptic-BMC (n = 4, receiving mouse BMC). The BMC suspension
was prepared for transplantation in saline at a density ofFig. 2. Effect treatment with bone marrow in the hippocampal cells. Nissl-stained secti
B = CA1; D = CA3; F = dentate gyrus] of epileptic rats and (B0 , D0 , F0; CA1, CA3 and dentat
transplantation). In the chronic phase (120 days after transplantation) (C = CA1; E = CA3
dentate gyrus, respectively). Scale bar = 100mm.1  107 cells/ml cells in 100 ml of total ﬂuid and was administered
by an intravenous route via the tail vein. The same volume of saline
was injected into the epileptic control animals.
2.6. Monitoring of spontaneous recurrent seizures
Groups of Li-pilo injected rats were video recorded during
different periods for the observation of motor seizure occurrence,
duration and severity of SE. The occurrence of recurrent class V
seizures according to Racine’s scale (showing forelimb clonus,
rearing and a loss of righting reﬂex)34 was quantiﬁed. First, all
seizures were observed during handling by direct observation of
rats in their home cages. Second, SE animals were video recorded
(light-sensitive black and white cameras - Sony, Brazil) from the
days 15 through 22 and from days 110 through 117 after SE, for
12 h per day (7.00 a.m. to 7.00 p.m.) to determine their epileptic
condition. After the last observation, the animals were submitted
to electrophysiological studies and histopathological analyses.
2.7. Electrophysiological studies
2.7.1. Slice preparation
Rats were anesthetized with thiopental (40 mg/kg, i.p.) before
decapitation. The brains were rapidly removed and cooled in
dissection artiﬁcial cerebrospinal ﬂuid containing (in mM): 130
NaCl, 3.5 KCl, 1.3 NaH2PO4, 5 Mg
2+, 0.2 CaCl2, 10 d-glucose and 24
NaHCO3, which was previously gassed with a 95% O2 and 5% CO2
mixture to obtain a pH value of 7.3–7.4. Subsequently, brains were
sectioned coronally and glued with cyanoacrylate to the stage of a
vibratome (Vibroslice 752M, Campden Instruments, Lafayette, IN,
USA). Four-hundredmmthick transversal hemisliceswere preparedons showing hippocampal structure [A = in a coronal section of non-epileptic rats,
e gyrus, respectively) from BMC-treated rats during epileptogenesis (10 days after
, G = dentate gyrus) of epileptic rats and BMC-treated rats (C0, E0 , G0 , CA1, CA3 and
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at least 1 h before being transferred to a submersion-type recording
chamber and placed on a nylon net submerged in normal artiﬁcial
cerebrospinalﬂuid (inmM:130NaCl, 3.5KCl, 1.3NaH2PO4, 2Mg
2+, 2Fig. 3. (A–C) Effect of Li-pilo-induced epilepsy and treatment with bone marrow on
cells on neuronal density. Comparisons of neuronal density per cubic millimeter
volume of tissue among different hippocampal sections were performed during
epileptogenesis (10 days after Li-Pilo) and/or during the chronic phase (120 days
after Li-Pilo) in BMC-epileptic, saline-epileptic and non-epileptic controls (2
hemispheres of 5 rats, per group). The groups were compared by one-way ANOVA
followed by Tukey post hoc test. *p < 0.05; **p < 0.01; ***p < 0.001 indicate
signiﬁcant differences compared to baseline; symbol (a) indicates a signiﬁcant
difference between the BMC-epilepsy and saline-epilepsy groups. AOI = area of
interest (800 mm2). Data are reported as mean  S.E.M.
Fig. 4. Effects of BMC treatment on hippocampal volume in Li-pilo-induced
epilepsy. The hippocampal volume analyzed (24.000mm3) was calculated from 5
rats in each group (non-epileptic control, saline-epileptic, and BMC-epileptic) killed
10 and 120 days after SE. The groups were compared by one-way ANOVA followed
by Tukey post hoc test. **p < 0.01; ***p < 0.001. Results are expressed as mean  S.D.CaCl2, 10 d-glucose and 24 NaHCO3, pH 7.4), which was continually
gassed with 95% O2 and 5% CO2 at room temperature.
2.7.2. Long-term potentiation (LTP) induction
Field potentialswere used in this study to avoid biasing the data
based on the activity of a single cell. The Schaffer collateral afferent
pathway of the hippocampal slice was stimulated (0.2 ms constant-
current pulses every 20 s) using a differential alternating current
(Isoﬂex M.P.I., Israel). The stimulation electrode consisted of a
twisted bipolar pair of 75mm platinum–iridium wires (A-M
Systems, Carlsborg,WA, USA). Borosilicate glass capillary electrodes
wereﬁlledwith0.9%NaCl solution (electrode impedance 2–20MV)
and placed in the dendritic region of the CA1 neurons (stratum
radiatum). Excitatory postsynaptic potentials (fEPSPs) were
recorded using an Axoclamp 1-D ampliﬁer (Axon Instruments,
Foster City, CA, USA) connected to a computer. At the beginning of
each recording, an input–output (I/O) curve for the fEPSP amplitude
relative to the stimulus intensity (increased in 50mA stepwise
manner ranging from 50 to 250mA) was recorded until fEPSP
amplitudes were saturated. This current intensity was adjusted to
evoke a baseline fEPSP amplitude that was 50–60% of the maximal
fEPSP amplitude obtained in the I/O curve.35 Baseline responses to
0.05 Hz paired-pulse stimuli (0.2 ms) were recorded for 20 min
before long-term potentiation induction. After a stable baseline-
evoked response was observed, the high-frequency stimulation
protocol was applied (four trains of 1 s duration at 100 Hz, pulse
duration of 0.2 ms, with an intertrain interval of 20 s). Field
potentials were monitored for at least 60 min after the tetanic
stimulus. Evoked fEPSPs were ampliﬁed and low-pass ﬁltered at
600 Hz (Cyber Amp 320, Axon Instruments), digitized (Digidata,
Axon Instruments) and recorded (Axoscope 9.2, Axon Instruments).
The amplitude of the evoked synaptic response was measured byTable 1
Effects of bone marrow cells on spontaneous seizures of Li-pilo-treated rats.
Treatment Period after
SE (days)
Seizure
frequency
Duration of
seizure (s)
Saline-epileptic
group (n=20)
15–21 1.0690.65a 42.66.93
110–117 1.7121.20a 40.07.22
BMC-epileptic
group (n=20)
15–21 0 N/A
110–117 0.0960.20a,b 20.55.28
Data are expressed as mean S.D.
a Spontaneous seizures of class V according to Racine’s scale, per day.
b p<0.0001 when compared to saline-epilepsy group.
Fig. 5. Presence of donor-derived cells in brains of epileptic rats. Photomicrographs of coronal sections obtained 24 h after transplantation, stained for visualization of NeuN+
(red) and GFP+ (green) cells in ectorhinal cortex (A), and hilus of GD (B). Section of the stratum radiatum of the hippocampus (C) obtained 48 h after transplantation showing
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normalized on a per recording basis and then plotted as themean of
2 min (6 fEPSPS) S.E.M. of one to three slices per rat, with 5 rats per
group per time point (i.e., 10–15 and 120–127 days after SE).
2.8. Neuronal density estimation
The animals were deeply anesthetized with thiopental (40 mg/
kg, i.p.) and transcardially perfused with saline solution followed
by a solution of 4% paraformaldehyde in 0.1 M phosphate buffer,
pH 7.4. The brains were removed from the skulls, post-ﬁxed in the
same solution at room temperature for 24 h and cryoprotected by
immersion in 30% sucrose solution in phosphate buffer at 4 8C until
they sank. The brains were then quickly frozen in isopentane that
was previously cooled in liquid nitrogen (70 8C).
Thirty-mm serial coronal sections obtained using a cryostat
(Leica, Germany) were mounted on poly-L-lysine coated slides,
stained with a solution of 0.01% cresyl violet and glacial acetic acid
0.01%, washed in distilled water, cleared in a graded series of
ethanol and xylene, and coverslipped for observation by light
microscopy [objects (20), Olympus AX 70 photomicroscope
coupled to a digital Leica DC 300F camera and Image-Pro Plus
Software 6.1 (Media Cybernetics, San Diego, CA, USA)].
Coronal sections from the hippocampus (stratum pyramidale of
the CA1 and CA3 subﬁelds) and hilus of the dentate gyrus were
identiﬁed according to Paxinos andWatson,37 and neuronal counts
were made between the coordinates of Bregma (1.46–3.64 mm).
Neuronswere identiﬁedmorphologically by their large, pale nuclei
surrounded by dark cytoplasm containing Nissl bodies. Glial cells
were identiﬁed and excluded from the counts by their relative size
and lack of stained cytoplasm. The nucleolus of the neuron was
used as the counting marker. Neuronal density (number of
neurons/mm3) was estimated using an adaptation of the optical
dissector method.38 Equidistant coronal sections of the brain were
analyzed in the rostral-caudal direction.
In a counting frame or area of interest (AOI), the nucleoli were
counted at different focal planes obtained during the course of
focusing through the tissue slice (in our case, Z axis = 30 mm).
Nucleoli found overlaying the left and upper borders of the
counting frame were counted together with the nucleoli located
within the analyzed square. In contrast, nucleoli overlaying the
right and lower border of the counting frame were not counted.
Neuronal density was estimated using the following formula:
Nv = (1/ah)(PQ/PP), where Nv = estimated neuronal density;
a = area of counting frame (800.00mm2); h = slice height (30 mm);
P
Q = sum of nucleoli counted;
P
P = sum of analyzed counting
frames. At least 10 counting frames were analyzed per region in
each hippocampus with 5 rats per group per time point.
2.9. Volume estimation
The Cavalieri method39,40 was used to estimate the volume of
the hippocampus. Cross sectional areas of the hippocampus were
captured (with 150mm intervals) using the image analysis system
previously described. The hippocampal formation was outlined
and measured. The boundaries of these regions were deﬁned in
accordance with criteria of Amaral and Witter,41 whereby the
hippocampal formation ‘‘hippocampus’’ was composed of three-
layered structures, including the dentate gyrus, the hippocampus
proper (CA1, CA2 and CA3 subﬁelds) and the subiculum. The
hippocampal volume was calculated by summation of the areasGFP+ cells (green). GFP+ cells (green) shown in sections of the CA1 region (E) and hilus (F
transplantation showing cells expressing microglia markers (F) and the (G) amygdalo
perirhinal cortex 120 days after transplantation showing GFP+ cells (green). DAPI-stained
microscopy, and the micrographs (D–F) by conventional ﬂorescence microscopy. Arrowanalyzed and multiplication of the distance between the sections
(150 mm). At least 10 areas were measured in each analyzed brain.
2.10. Immunoﬂuorescence analysis
Following euthanasia, rat brains were ﬁxed by transcardial
perfusion with saline, which was followed by perfusion and
immersion in 4% paraformaldehyde. After post-ﬁxation overnight,
brains were cryoprotected and frozen in methylbuthane at80 8C.
A series of 20 mm thick sections were obtained, with 9 sections per
animal at various levels (100 mm interval) from the BMC-mouse-
epileptic group: n = 12, BMC-rat-epileptic group: n = 5, and BMC-
control group: n = 3. To detect the distribution of transplanted
BMCs in other organs (liver, lung, spleen, and heart), three sections
(20mm thick, 100mm interval) from each organ were obtained.
Sections were incubated with biotinylated anti-neuronal nuclei
antibody (NeuN, 1:100, Chemicon International, Temecula, CA,
USA), rabbit anti-GFAP (1:400; Dako North America Inc., CA, USA),
and chicken anti-GFP (1:400, Aves Labs Inc., Oregon, USA). After
incubation overnight, the slices were washing twice for 5 min in
PBS Tween 0.05% and in PBS. Sections were incubated with
streptavidin-Alexa Fluor 555-conjugated or goat anti-rabbit IgG
Alexa Fluor 568-conjugated and goat anti-chicken IgG Alexa Fluor
488-conjugated antibodies (all secondary antibodies were used at
a dilution of 1:200, Invitrogen-Molecular Probes, Carlsbad, CA,
USA) for 1 h at room temperature. Sections were washed twice in
PBS Tween 0.05% and in PBS, dried and coverslipped using
Vectashield mounting medium with 40,6-diamidino-2-phenylin-
dole (DAPI; Vector Laboratories, California, USA).
Brains of the rats transplanted with Qtracker-stained BMC were
frozen at 20 8C and 30mm thick slices of the dorsal hippocampus
were ﬁxed in 4% paraformaldehyde and dried and coverslipped
using Vectashield mounting medium with 4,6-diamidino-2-phe-
nylindole (DAPI; Vector Laboratories, California, USA). Negative
control sections from each animal received identical treatment,
except than the primary antibodies were omitted. The presence of
ﬂuorescent cells was determined by observation with a BX61
microscope (Olympus) using appropriate ﬁlters or using a confocal
microscope (FV 1000 Olympus Inc., Japan). Images were captured
using a color digital video SPOT ﬂex camera (15.2, 64 Mp, Shifting
Pixel, Diagnostic Instruments Inc., USA).
2.11. Statistical analysis
Data are presentedasmean  S.D. ormean  S.E.M. as indicated in
the ﬁgure legends. A two-sided, nonpaired t-test was used to analyze
the ﬂowcytometry, aswell as differences in SRS end duration.Weused
one-way analysis of variance (ANOVA), followed by the Tukey Kramer
multiple comparisons test to evaluate neuronal density, volume
estimationandelectrophysiologicaldata.Theanalysesweredoneusing
Origin version 5.0 (Microcal Software Inc., Northampton,MA, USA) and
Prism version 4.0 (GraphPad Software, San Diego, CA) software.
Differences were considered signiﬁcant at p < 0.05.
3. Results
3.1. Transplantation of BMCs prevents spontaneous seizures in
pilocarpine-treated rats
The epileptic rats developed status epilepticus (class V of
Racine’s scale) with a mean latency of 31.57  10.41 s. The duration) 3 and 5 days after transplantation, respectively. Section of the plexus 10 days after
striatal transition area showed GFAP+ (red) and GFP+ (green) cells. (H) Section of
nuclei are shown in blue. Images (A)–(C) and (G) and (H) were obtained by confocal
s indicate GFP+ cells. Bar = 100mm.
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was 30% (24/80) for the BMC-epileptic group; 20% (1/5) for the BMC-
rat-epileptic group and 40% (14/50) for the saline-epileptic group. No
mortality was observed after this period. A relationship between the
latent period duration (i.e., the interval between Li-pilo-induced SE)
and the ﬁrst SRS was not observed. However, 80% of the animals had
seizures in the ﬁrst day of video recording and all animals had SRS
during the second day of observation (from days 15 to 21 after SE). All
rats in the saline-epileptic group developed SRS, whereas none of the
BMC-epileptic group had seizures (Table 1). For evaluation of the
chronic phase (120 days post-transplantation), all animals in the
saline-epileptic group developed SRS, whereas only 25% of BMC-
epilepsy animals did. In addition, this group exhibited a lower seizure
frequency and duration compared to the saline-epileptic group
(p < 0.0001; Table 1).
3.2. Electrophysiological studies and LTP induction
Next, we examined the electrophysiological properties of rat
brain sections from the different experimental groups. Stimulation
of Schaffer collaterals elicited ﬁeld excitatory post-synaptic
potentials (fEPSPs) in slices prepared from non-epileptic control
rats (Fig. 1A-a), whereas this response was attenuated in saline-
epileptic animals (Fig. 1A-b) 10 days after SE. An incremental
increase in fEPSPs amplitude from BMC-epileptic animals (Fig. 1A-
c) was observed compared to saline-epileptic animals. In contrast,
120 days after SE, this responsewasmarkedly attenuated in saline-
epileptic rats (Fig. 1A-e) and similar fEPSP amplitudes were
observed in BMC-epilepsy rats (Fig. 1A-f) compared to non-
epileptic control rats (Fig. 1A-d).
We further examined changes in fEPSP amplitude following
tetanic stimulation to induce long-term potentiation in slices that
showed typical postsynaptic responses (10 days after SE, Fig. 1B).
The normalized amplitude obtained from brain slices of saline-
epileptic animals (104.1  12.49 mV) was signiﬁcantly lower
compared to non-epileptic controls (213.1  19.61 mV; p < 0.001).
In contrast, the amplitude was signiﬁcantly increased in BMC-
epileptic rats (180.3  14.25 mV), which was not statistically
different when compared to non-epileptic control animals (p > 0.05).
In the chronic phase (120 days after SE), the amplitude was
signiﬁcantly reduced in slices obtained from brains of saline-
epileptic rats (97.33  5.6 mV) compared to non-epileptic controls
(175.2  12.85 mV; p < 0.001). In contrast, a signiﬁcant potentiation
could also be detected in the BMC-epilepsy rats (174.4  15.75 mV)
compared to non-epileptic controls (p > 0.05; Fig. 1C).
3.3. Epilepsy-induced changes in hippocampal volume and cell loss
are attenuated by transplantation of BMC
Qualitative analysis of Nissl-stained neurons showed no
histological lesions in normal control groups (Fig. 2A). In contrast,
there was substantial neuronal loss accompanied by gliosis in the
stratum pyramidale of the hippocampal subﬁelds. Some of the
remaining neurons appeared shrunken, with pycnotic nuclei in the
epileptic rats (Fig. 2B–G). In epileptic rats treated with BMC,
neuronal lesions were less extended than in epileptic rats (Fig. 2B0–
G0).
As demonstrated by the quantitative analysis 10 days after SE,
brain sections from animals of the saline-epileptic group had a
severe reduction in the neuronal density of the CA1 subﬁeld of the
hippocampus (50.1% when compared to non-epileptic control
animals; p < 0.001). Although a reduction of 34.3% was also
observed in the BMC-epileptic animals compared to non-epileptic
rats (p < 0.00), the number of neurons in BMC-epilepsy animals
was signiﬁcantly higher than saline-epileptic animals (p < 0.05).
After 120 days of SE, the most severe damage was seen in saline-epileptic rats, which had a 76.9% decrease in the number of
neurons compared to non-epileptic controls (p < 0.001), thereby
showing a progression of pathologies compared to sections
obtained 10 days after SE. In contrast, BMC-epileptic animals
had moderate neuronal loss (32.0%) compared to controls, and
about 3-fold more neurons than saline-epileptic animals
(p < 0.001, Fig. 3A).
In the CA3 subﬁeld of the hippocampus, a reduction in neuronal
densitywas observed in the saline-epileptic groupwhen compared
with non-epileptic controls 10 days (26.3%; p < 0.01) and 120 days
(34.1%; p < 0.001) after SE. In this region, the differences in
neuronal density of BMC-epileptic animals were not statistically
different than control animals during both time points analyzed
(p > 0.05; Fig. 3B). Similarly, a decrease in neuronal density was
seen 10 and 120 days after SE in the saline-epileptic group in the
hilus of the dentate gyrus (34%, p < 0.05 and 45%, p < 0.01;
respectively). In contrast, no signiﬁcant differences were found in
BMC-epileptic rats compared to control animals for both time
points analyzed (Fig. 3C).
Measurements of hippocampal volume revealed decreases in
this parameter in saline-epileptic rats 10 and 120 days after SE
when compared with non-epileptic controls (p < 0.01 and
p < 0.001, respectively). In addition, a signiﬁcant decrease was
observed in saline-epileptic animals 120 days after SE compared to
this group 10 days after SE (p < 0.01). When BMC-epileptic rats
were compared to non-epileptic controls, no signiﬁcant differences
were found for both time points analyzed (p > 0.05). Moreover, a
signiﬁcant difference (p < 0.001) was found when BMC-epileptic
rats were compared to saline-epileptic rats at 120 days, but not 10
days after SE (p > 0.05; Fig. 4).
3.4. Migration of donor-derived BMC to the epileptic brain
To investigate the presence of transplanted BMC in the brains of
BMC-epileptic rats, animals were killed 1–3, 5, 10 and 120 days
after SE. BMCs survived and were distributed throughout the
damaged brain of recipient rats. These BMCs were localized to the
cortex and/or hippocampus after transplantation for 24 h (Fig. 5A
and B), 48 h (Fig. 5C), 3 and 5 days (Fig. 5D and E, respectively).
After 10 and 120 days of transplantation, GFP+ cells were also
found in the perirhinal cortex and basomedial amygdale (Fig. 5F
and G, respectively). We did not observe GFP+ cells co-stained with
NeuN or GFAP at any time point analyzed. Bone marrow cells
obtained from rats and incubated with a Q-dot tracer were
distributed throughout the damaged brain at all time points
analyzed. Fig. 5H shows the expressed Q-dot tracer (red) in the
24 h post-transplantated brain. Although donor cells were not
found in brains of normal animals transplanted with GFP+ cells
(BMC-control group, n = 4), they were found in other organs such
as spleen, lung, kidney and heart (data not show). In addition, we
did not ﬁnd any tissue damage or tumor formation in animals
transplanted with BMCs, and no systemic complications or
increased morbidity were associated with intravenous injections
of BMCs in the epileptic animals.
4. Discussion
The present study was designed to test the hypothesis that
transplantation of bone marrow cells in the acute phase of
epileptogenesis prevents the development of epilepsy in the
pilocarpine model. In our study, the pathologies induced by
pilocarpine injection indicated that our model is in accordance
with other data published.42 Most importantly, a signiﬁcant
improvement in the behavioral manifestations of animals treated
was found in animals submitted to BMC therapy. In the short-term
analysis, we observed that animals treated with BMCs did not
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animals treated with BMC developed SRS, although with a lower
frequency and duration when compared to the epileptic rats
(Table 1). These results demonstrate that BMCs administered by
an intravenous route after Li-pilo induced SE can suppress the
manifestation of early SRS, and signiﬁcantly reduce epileptogen-
esis, since only 25% of animals showed less severe seizures 4
months post-SE and after transplantation of BMCs.
The timing of neuronal death induced by pilocarpine SE may be
critical. Some studies have reported that 24 h after SE, edema was
present in the amygdala, piriform cortex and entorhinal cortex,
which was accompanied by extensive neuronal loss, whereas the
process was delayed in CA1 and CA3 neurons.43 These results
suggest that the injury of the piriform and entorhinal cortices
during SE is predictive of further epilepsy.44 In this study, we found
that BMCs probably exert a neuroprotective effect by preventing
the neuronal damage caused by pilocarpine in the hippocampal
formation. This effect may be related to the fact that transplanta-
tion took place immediately after termination of SE.
Our data show that intravenously injected bone marrow cells
from rats or GFP transgenic mice can gain access to the brain of
epileptic rats. Also, we have found that this migration occurs as
early as one day after intravenous injection. However, the number
of cells that enter organ tissue is relatively small in both rats
submitted to allogenic or to xenogenic transplantation. Between 1
and 120 days after grafting, we observed that the donor cells were
found to be distributed throughout the whole brain. We did not
ﬁnd donor-derived cells expressing the neuronal (NeuN) or
astrocyte (GFAP) cell markers.
The mechanisms by which transplanted BMCs induce function-
al beneﬁts after epileptic induction are not clear. Acute brain
insults (e.g., stroke and SE) have an inﬂammatory component,45,46
which contributes to the progression of neuropathological
events.47 In addition, we have found in a model of chronic
chagasic cardiomyopathy that i.v. transplantation of BMCs
decreased inﬂammation in the heart.48 Moreover, the intravenous
administration of BMCs and the migration of these cells into the
injured tissue may provide trophic factors such as the hematopoi-
etic cytokine, which is also a growth factor in the central nervous
system.49 Herein, we also found that some GFP+ cells were seen in
every analyzed brain section from transplanted mice. These data
indicate that, despite their minimal retention in the brain, BMCs
can cause functional improvement. In support of our work, others
have shown functional recovery using a similar therapeutic
modality of BMC treatment after brain ischemia,16–21 or demye-
linating injuries of the spinal cord.50,51
Integration of newly formed neurons into the excitatory neural
circuitry is a pre-requisite for the reconstitution of brain function.
The axonal wiring in the mammalian central nervous system is
organized in a precise ‘point-to-point’ manner.52,53 The entorhi-
nal–hippocampal excitatory projection is the ﬁrst connection of
the trisynaptic circuit, which is suggested to be involved in the
formation of learning and memory.54,55 Previous reports have
indicated that LTP is composed of two independent components.
These include synaptic and EPSP-to-spike coupling components, as
evidenced by an increase in the fEPSP slope and in the population
spike amplitude, respectively.56 In the present study, we found
that treatment with BMCs exerted protective effects on LTP since
treated epileptic rats had a higher amplitude fEPSP compared to
epileptic animals during early epileptogenesis (10 days after SE)
and/or during chronic epilepsy (120 days after SE). Interestingly, at
this latter time point, no signiﬁcant differences were noted in the
fEPSP slope at the induction of LTP compared to non-epileptic
control rats. This suggests an increase in the efﬁciency of synaptic
transmission and/or in the excitability of the postsynaptic neuron
after BMC therapy. The successful LTP induction in hippocampalslices supports the idea that the transplanted BMCs participate in
the preservation or regeneration of the synaptic circuitry involved
with LTP. These results clearly demonstrate that transplantation of
BMCs signiﬁcantly ameliorate the function of synapses in the
hippocampus of BMC-epileptic rats.
In conclusion, our results are the ﬁrst proof of principle for
bone marrow cell therapy in epileptic rats. BMCs have several
advantages for transplantation. First, autologous BMCs can be
used, thus circumventing the problems of host immunity. Second,
intravenous transplantation of BMCs may be an efﬁcient
therapeutic approach. Third, the use of freshly isolated cells does
not require culture expansion. In addition, since epileptogenesis is
a dynamic process with severe consequences and cognitive
deterioration57,58; the time course of disease should be consid-
ered for therapeutic cell transplantation in order to prevent
additional epileptic dysfunction. Further studies will be essential
to elucidate the mechanism through which intravenous trans-
plantation of BMCs promotes functional recovery after status
epilepticus.
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